"Dyslipidemias" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Descriptor ID |
D050171
|
| MeSH Number(s) |
C18.452.584.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dyslipidemias".
Below are MeSH descriptors whose meaning is more specific than "Dyslipidemias".
This graph shows the total number of publications written about "Dyslipidemias" by people in this website by year, and whether "Dyslipidemias" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 2 | 2 | 4 |
| 2006 | 7 | 0 | 7 |
| 2007 | 2 | 2 | 4 |
| 2008 | 5 | 1 | 6 |
| 2009 | 4 | 1 | 5 |
| 2010 | 5 | 2 | 7 |
| 2011 | 9 | 4 | 13 |
| 2012 | 7 | 1 | 8 |
| 2013 | 9 | 2 | 11 |
| 2014 | 5 | 1 | 6 |
| 2015 | 7 | 6 | 13 |
| 2016 | 8 | 4 | 12 |
| 2017 | 5 | 1 | 6 |
| 2018 | 11 | 1 | 12 |
| 2019 | 18 | 0 | 18 |
| 2020 | 10 | 2 | 12 |
| 2021 | 6 | 4 | 10 |
| 2022 | 6 | 0 | 6 |
| 2023 | 4 | 0 | 4 |
| 2024 | 3 | 1 | 4 |
| 2025 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dyslipidemias" by people in Profiles.
-
Genetic Contribution to Treatment-Related Dyslipidemia in Adult Survivors of Childhood Cancer: Findings from the CCSS, SJLIFE, and DCCSS-LATER Cohorts. Cancer Epidemiol Biomarkers Prev. 2025 Nov 03; 34(11):2068-2076.
-
Visit-to-visit lipid variability, coronary artery calcification, inflammation, and mortality in the Multi-Ethnic Study of Atherosclerosis. Eur J Prev Cardiol. 2025 Sep 22; 32(13):1235-1244.
-
Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial. J Am Heart Assoc. 2025 Mar 04; 14(5):e038656.
-
Does Adopting Western Low-density Lipoprotein Cholesterol Targets Expose Indians to a Higher Risk of Cardiovascular Events? Expert Opinion From the Lipid Association of India. J Assoc Physicians India. 2024 Oct; 72(10):71-76.
-
Prevalence of Cardiometabolic Risk Factors in Women: Insights From the Houston HeartReach Study. Tex Heart Inst J. 2024 09 27; 51(2).
-
Dyslipidemia management in women of reproductive potential: An Expert Clinical Consensus from the National Lipid Association. J Clin Lipidol. 2024 Sep-Oct; 18(5):e664-e684.
-
The Tehran longitudinal family-based cardiometabolic cohort study sheds new light on dyslipidemia transmission patterns. Sci Rep. 2024 02 27; 14(1):4739.
-
The association between dyslipidaemia in the first trimester and adverse pregnancy outcomes in pregnant women with subclinical hypothyroidism: a cohort study. Lipids Health Dis. 2024 Jan 11; 23(1):13.
-
Stunted Growth Is Associated With Dyslipidemia in Young Adults With Perinatal HIV Infection. J Acquir Immune Defic Syndr. 2023 08 01; 93(4):343-350.
-
Algorithms for Treating Dyslipidemia in Youth. Curr Atheroscler Rep. 2023 08; 25(8):495-507.